Medtronic develops healthcare technology to treat chronic disease. Its medical technology is providing lifelong solutions for people with chronic pain. Medtronic has four main business units: the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group. Medtronic develops and manufactures devices and therapies to treat more than 30 chronic diseases that include heart failure, Parkinson disease, urinary incontinence, Down syndrome, obesity, chronic pain, spinal disorders, and diabetes.

Research Grants 37 show all


$13.6M
2014

$279.2K
2015

$209.6K
2016

$9.2M
2017

$417.7K
2018

Patents 33,195show all

  • 11,164
    A61N - Electrotherapy
  • 8,471
    A61B - Diagnosis
  • 5,291
    A61M - Devices for introducing media into, or onto, the body
  • 3,283
    A61F - Filters implantable into blood vessels
  • 1,328
    A61L - Methods or apparatus for sterilising materials or objects in general
  • 1,235
    G06F - Electric digital data processing
  • 1,090
    G16H - Healthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data
  • 855
    A61K - Preparations for medical, dental, or toilet purposes
  • 488
    H01M - Processes or means, e.g. batteries, for the direct conversion of chemical into electrical energy
  • 454
    G01N - Investigating or analysing materials by determining their chemical or physical properties

Clinical Trials 774show all

396N/A91Phase 438Phase 345Other

SEC Filings show all


184
8-K

64
10-Q

22
10-K

Contact Information

710 Medtronic Parkway
Minneapolis, MN 55432-5604
United States

Overview

Total FundingEmployeesLast Funding DateStatus
$20,000,00010000+2016-08-15Ipo

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2016-08-15$20,000,000Post Ipo EquityTrade Capital Funding